Melorheostosis: Difference between revisions
CSV import |
CSV import |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{SI}} | |||
{{Infobox medical condition | |||
| name = Melorheostosis | |||
| image = [[File:Meloreostosi_arto_superiore_sinistro.jpg|left|thumb|X-ray of melorheostosis in the left upper limb]] | |||
| caption = X-ray showing melorheostosis in the left upper limb | |||
| synonyms = Leri's disease | |||
| pronounce = | |||
| specialty = [[Orthopedics]], [[Rheumatology]] | |||
| symptoms = [[Pain]], [[stiffness]], [[deformity]] | |||
| onset = Childhood or early adulthood | |||
| duration = Chronic | |||
| causes = [[Genetic mutation]] | |||
| risks = | |||
| diagnosis = [[X-ray]], [[MRI]], [[CT scan]] | |||
| differential = [[Osteosarcoma]], [[Osteopoikilosis]], [[Osteopathia striata]] | |||
| treatment = [[Pain management]], [[physical therapy]], [[surgery]] | |||
| medication = [[Analgesics]], [[NSAIDs]] | |||
| frequency = Rare | |||
| deaths = | |||
}} | |||
'''Melorheostosis''' is a rare, non-hereditary [[skeletal disorder]] characterized by irregular, flowing hyperostosis of the [[cortex]] of tubular bones. The condition was first described in 1922 by Leri and Joanny, and its name is derived from the Greek words ''melos'' (limb), ''rhein'' (to flow), and ''ostosis'' (condition of the bone). | '''Melorheostosis''' is a rare, non-hereditary [[skeletal disorder]] characterized by irregular, flowing hyperostosis of the [[cortex]] of tubular bones. The condition was first described in 1922 by Leri and Joanny, and its name is derived from the Greek words ''melos'' (limb), ''rhein'' (to flow), and ''ostosis'' (condition of the bone). | ||
==Epidemiology== | ==Epidemiology== | ||
Melorheostosis affects both sexes equally and can manifest at any age, although it is typically diagnosed in early adulthood. The prevalence of the condition is estimated to be 0.9 per million. | Melorheostosis affects both sexes equally and can manifest at any age, although it is typically diagnosed in early adulthood. The prevalence of the condition is estimated to be 0.9 per million. | ||
==Pathophysiology== | ==Pathophysiology== | ||
The pathophysiology of melorheostosis is not fully understood. It is believed to be caused by a somatic mutation in the [[MAP2K1]] gene, which leads to increased activity of the [[MEK1]] protein and subsequent hyperostosis. The condition is not inherited but occurs sporadically. | The pathophysiology of melorheostosis is not fully understood. It is believed to be caused by a somatic mutation in the [[MAP2K1]] gene, which leads to increased activity of the [[MEK1]] protein and subsequent hyperostosis. The condition is not inherited but occurs sporadically. | ||
==Clinical Presentation== | ==Clinical Presentation== | ||
Patients with melorheostosis often present with pain, stiffness, and functional impairment of the affected limb. The condition can also cause deformities and contractures. Radiographically, melorheostosis is characterized by dense, flowing hyperostosis of the cortex of tubular bones, often described as "dripping candle wax" appearance. | Patients with melorheostosis often present with pain, stiffness, and functional impairment of the affected limb. The condition can also cause deformities and contractures. Radiographically, melorheostosis is characterized by dense, flowing hyperostosis of the cortex of tubular bones, often described as "dripping candle wax" appearance. | ||
==Diagnosis== | ==Diagnosis== | ||
The diagnosis of melorheostosis is primarily based on clinical and radiographic findings. [[Computed tomography]] (CT) and [[magnetic resonance imaging]] (MRI) can be used to further characterize the lesion and assess the extent of the disease. | The diagnosis of melorheostosis is primarily based on clinical and radiographic findings. [[Computed tomography]] (CT) and [[magnetic resonance imaging]] (MRI) can be used to further characterize the lesion and assess the extent of the disease. | ||
==Treatment== | ==Treatment== | ||
There is currently no cure for melorheostosis. Treatment is symptomatic and may include pain management, physical therapy, and in some cases, surgery to correct deformities or contractures. | There is currently no cure for melorheostosis. Treatment is symptomatic and may include pain management, physical therapy, and in some cases, surgery to correct deformities or contractures. | ||
==Prognosis== | ==Prognosis== | ||
The prognosis of melorheostosis varies depending on the severity and extent of the disease. While the condition is not life-threatening, it can significantly impact the patient's quality of life due to pain and functional impairment. | The prognosis of melorheostosis varies depending on the severity and extent of the disease. While the condition is not life-threatening, it can significantly impact the patient's quality of life due to pain and functional impairment. | ||
==See Also== | ==See Also== | ||
* [[Osteosclerosis]] | * [[Osteosclerosis]] | ||
* [[Osteopathia striata]] | * [[Osteopathia striata]] | ||
* [[Osteopoikilosis]] | * [[Osteopoikilosis]] | ||
[[Category:Rare diseases]] | [[Category:Rare diseases]] | ||
[[Category:Skeletal disorders]] | [[Category:Skeletal disorders]] | ||
[[Category:Genetic disorders]] | [[Category:Genetic disorders]] | ||
{{stub}} | {{stub}} | ||
Latest revision as of 21:45, 6 April 2025
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD medical weight loss NYC and sleep center NYC
| Melorheostosis | |
|---|---|
 | |
| Synonyms | Leri's disease |
| Pronounce | |
| Specialty | Orthopedics, Rheumatology |
| Symptoms | Pain, stiffness, deformity |
| Complications | N/A |
| Onset | Childhood or early adulthood |
| Duration | Chronic |
| Types | N/A |
| Causes | Genetic mutation |
| Risks | |
| Diagnosis | X-ray, MRI, CT scan |
| Differential diagnosis | Osteosarcoma, Osteopoikilosis, Osteopathia striata |
| Prevention | N/A |
| Treatment | Pain management, physical therapy, surgery |
| Medication | Analgesics, NSAIDs |
| Prognosis | N/A |
| Frequency | Rare |
| Deaths | |
Melorheostosis is a rare, non-hereditary skeletal disorder characterized by irregular, flowing hyperostosis of the cortex of tubular bones. The condition was first described in 1922 by Leri and Joanny, and its name is derived from the Greek words melos (limb), rhein (to flow), and ostosis (condition of the bone).
Epidemiology[edit]
Melorheostosis affects both sexes equally and can manifest at any age, although it is typically diagnosed in early adulthood. The prevalence of the condition is estimated to be 0.9 per million.
Pathophysiology[edit]
The pathophysiology of melorheostosis is not fully understood. It is believed to be caused by a somatic mutation in the MAP2K1 gene, which leads to increased activity of the MEK1 protein and subsequent hyperostosis. The condition is not inherited but occurs sporadically.
Clinical Presentation[edit]
Patients with melorheostosis often present with pain, stiffness, and functional impairment of the affected limb. The condition can also cause deformities and contractures. Radiographically, melorheostosis is characterized by dense, flowing hyperostosis of the cortex of tubular bones, often described as "dripping candle wax" appearance.
Diagnosis[edit]
The diagnosis of melorheostosis is primarily based on clinical and radiographic findings. Computed tomography (CT) and magnetic resonance imaging (MRI) can be used to further characterize the lesion and assess the extent of the disease.
Treatment[edit]
There is currently no cure for melorheostosis. Treatment is symptomatic and may include pain management, physical therapy, and in some cases, surgery to correct deformities or contractures.
Prognosis[edit]
The prognosis of melorheostosis varies depending on the severity and extent of the disease. While the condition is not life-threatening, it can significantly impact the patient's quality of life due to pain and functional impairment.
